Translational Development Acquisition Corp.
Translational Development Acquisition Corp. (TDAC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
tdac · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Translational Development Acquisition Corp. (TDAC) measures how much investors pay for each dollar of the company's trailing earnings. TDAC's current PE ratio of 29.88x is calculated by dividing its stock price of $10.76 by its TTM earnings per share of $0.36. +5.1% elevated vs 5Y avg 28.4x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2022 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Translational Development Acquisition Corp.You TDAC | $236M | 29.88x | -25.8% | $0.36 |
 Cantor Equity Partners, Inc. Class A Ordinary Shares CEP | $178M | 86.48x | +114.8% | $0.12 |
 Cantor Equity Partners I, Inc. Class A Ordinary Shares CEPO | $218M | N/A | — | -$0.26 |
 FACT II Acquisition Corp FACT | $259M | 38.36x | -4.7% | $0.27 |
 HCM Acquisition Corp HCMA | $135M | 18.59x | -53.8% | $0.55 |
 Melar Acquisition Corp. I MACI | $234M | 30.70x | -23.7% | $0.35 |
 Newbury Street II Acquisition Corp NTWO | $191M | 27.17x | -32.5% | $0.38 |
Industry Average 5 peers with valid PE | — | 40.26x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 28.44x | $0.37 | — | |
2024-12-31 FY2024 | — | $-0.02 | — | |
2023-12-31 FY2023 | — | $-0.12 | — | |
2022-12-31 FY2022 | — | $-0.02 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Translational Development Acquisition Corp. (TDAC) measures how much investors pay for each dollar of the company's trailing earnings. TDAC's current PE ratio of 29.88x is calculated by dividing its stock price of $10.76 by its TTM earnings per share of $0.36.
Frequently asked questions
TDAC pe ratio · 6 questionsTDAC's current PE ratio is 29.88x as of 2026-06-08, based on a stock price of $10.76 and TTM EPS of $0.36. Data sourced from Financial Modeling Prep via TDAC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Translational Development Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08